tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CADL Stock Latest News

Candel Therapeutics downgraded to Neutral at BofA on lack of catalysts
The FlyCandel Therapeutics downgraded to Neutral at BofA on lack of catalysts
6d ago
CADL
Candel Therapeutics downgraded to Neutral from Buy at BofA
PremiumThe Fly
Candel Therapeutics downgraded to Neutral from Buy at BofA
6d ago
CADL
Candel Therapeutics appoints Carl June to Research Advisory Board
PremiumThe Fly
Candel Therapeutics appoints Carl June to Research Advisory Board
7d ago
CADL
Candel Therapeutics Extends Lease Agreement in Needham
PremiumCompany Announcements
Candel Therapeutics Extends Lease Agreement in Needham
19d ago
8K
CADL
Candel Therapeutics Advances with Promising Cancer Therapies
PremiumCompany Announcements
Candel Therapeutics Advances with Promising Cancer Therapies
21d ago
CADL
Candel Therapeutics Faces Uncertainty Despite FDA RMAT Designation for Prostate Cancer Treatment
PremiumCompany AnnouncementsCandel Therapeutics Faces Uncertainty Despite FDA RMAT Designation for Prostate Cancer Treatment
25d ago
CADL
Candel Therapeutics’ CAN-2409: Promising Phase 3 Results and Market Potential
Premium
Ratings
Candel Therapeutics’ CAN-2409: Promising Phase 3 Results and Market Potential
26d ago
CADL
Candel Therapeutics: Promising Pipeline Developments and Strategic Advancements Support Buy Rating
Premium
Ratings
Candel Therapeutics: Promising Pipeline Developments and Strategic Advancements Support Buy Rating
26d ago
CADL
Candel Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Candel Therapeutics files $300M mixed securities shelf
26d ago
CADL
Candel Therapeutics reports Q2 EPS (9c) vs. (74c) last year
PremiumThe Fly
Candel Therapeutics reports Q2 EPS (9c) vs. (74c) last year
26d ago
CADL
Candel Therapeutics sees cash runway into 1Q27
PremiumThe Fly
Candel Therapeutics sees cash runway into 1Q27
26d ago
CADL
Candel Therapeutics receives EMA Orphan Designation for CAN-2409
PremiumThe Fly
Candel Therapeutics receives EMA Orphan Designation for CAN-2409
2M ago
CADL
Candel Therapeutics: Promising Phase 3 Data and Strong Financial Runway Justify Buy Rating
PremiumRatingsCandel Therapeutics: Promising Phase 3 Data and Strong Financial Runway Justify Buy Rating
2M ago
CADL
Candel Therapeutics initiated with a Buy at Brookline
Premium
The Fly
Candel Therapeutics initiated with a Buy at Brookline
2M ago
CADL
Candel Therapeutics announces addition to multiple Russell Indexes
Premium
The Fly
Candel Therapeutics announces addition to multiple Russell Indexes
2M ago
CADL
Candel Therapeutics assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Candel Therapeutics assumed with a Buy at H.C. Wainwright
2M ago
CADL
Candel Therapeutics Announces $15M Stock Offering
PremiumCompany Announcements
Candel Therapeutics Announces $15M Stock Offering
3M ago
8K
CADL
Candel Therapeutics prices 3.2M shares at $4.67 in registered direct offering
PremiumThe Fly
Candel Therapeutics prices 3.2M shares at $4.67 in registered direct offering
3M ago
CADL
Candel Therapeutics Appoints Charles Schoch as CFO
PremiumCompany Announcements
Candel Therapeutics Appoints Charles Schoch as CFO
3M ago
8K
CADL
Candel Therapeutics appoints Charles Schoch as CFO
PremiumThe FlyCandel Therapeutics appoints Charles Schoch as CFO
3M ago
CADL
Candel Therapeutics Elects New Directors at Annual Meeting
Premium
Company Announcements
Candel Therapeutics Elects New Directors at Annual Meeting
3M ago
8K
CADL
Promising Potential of Candel Therapeutics in Prostate Cancer Treatment: A High-Risk, High-Reward Investment Opportunity
Premium
Ratings
Promising Potential of Candel Therapeutics in Prostate Cancer Treatment: A High-Risk, High-Reward Investment Opportunity
3M ago
CADL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >